Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U3WQ
|
|||
| Former ID |
DIB018776
|
|||
| Drug Name |
AGL 2043
|
|||
| Synonyms |
AGL-2043; HMS3229A05; AGL2043
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C15H12N4S
|
|||
| Canonical SMILES |
CC1=NC2=C(N1C)C=C3C(=C2)N=C(C=N3)C4=CC=CS4
|
|||
| InChI |
1S/C15H12N4S/c1-9-17-12-6-11-10(7-14(12)19(9)2)16-8-13(18-11)15-4-3-5-20-15/h3-8H,1-2H3
|
|||
| InChIKey |
ZGDACLBJJXLKJY-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 226717-28-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit. Bioorg Med Chem. 2003 May 1;11(9):2007-18. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.